Compare Corning Incorporated (GLW) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs BIO-TECHNE Corp — how do they compare? Corning Incorporated trades at $157 (market cap $140.62B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: Corning Incorporated is far larger — about 12.4× BIO-TECHNE Corp's market cap, and Corning Incorporated pays the higher dividend (0.69%). Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 35 Days and BIO-TECHNE Corp for 63 Days on average.
| GLW | TECH | |
|---|---|---|
Market Cap | $140.62B | $11.37B |
Volume | 5,163,560 | 3,153,511 |
Sector | Technology | Health |
52-Week High | $255.79 | $72.61 |
52-Week Low | $78.03 | $43.31 |
Typical Hold Time | 35 Days | 63 Days |
Enterprise Value | $147.50B | $11.40B |
Dividend Yield | 0.69% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $152.81, down 9.57% despite recent positive catalysts including a $3B AT&T fiber supply agreement. The stock shows strong fundamentals with revenue growth from $13.1B to $15.6B in 2025 and net income surging to $1.6B. Technical indicators show bullish momentum with the current price below key resistance levels. Analyst consensus remains positive with 57% buy ratings and a $171.25 price target representing 12% upside potential.
GLW presents a compelling opportunity driven by AI infrastructure demand and the AT&T partnership, though elevated valuation metrics (P/E 75.23) and ongoing patent litigation create near-term headwinds. The company's strong cash flow generation and dividend payments support shareholder returns while expansion in fiber optics positions it for sustained growth in the connectivity ecosystem.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
